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Abstract The study objective was clinical assessment of
the efficacy of photodynamic therapy (PDT) in the treatment
of oral lichen planus (OLP). There were 23 patients aged
31–82 included in the study with oral lichen planus diag-
nosed clinically and histopathologically. In all patients pho-
todynamic therapy was performed with the use of chlorin e6
(Photolon®), containing 20 % chlorin e6 and 10 % dimethyl
sulfoxide as a photosensitizer. PDT was performed using a
semiconductor laser, with power up to 300 mW and a
wavelength of 660 nm. A series of illumination sessions
was conducted with the use of superficial light energy
density of 90 J/cm2. Changes of lesion size were monitored
at one, two, five, and ten PDT appointments from the series
of ten according to the authors' own method. The sizes of
clinical OLP lesions exposed to PDT were reduced signifi-
cantly (on average by 55 %). The best effects were observed
for the lesions on the lining mucosa (57.6 %). The therapy
was statistically significantly less effective when masticatory
mucosa was affected (reduction, 30.0 %). Due to substantial
efficacy and noninvasiveness, PDT can be useful in the treat-
ment of OLP lesions.
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Introduction
Oral lichen planus (OLP) is one of the most common poten-
tially carcinogenic chronic diseases of oral mucosa [1]. As its
etiopathology cannot be established, treatment is usually
symptomatic, thus showing low predictability [2–7]. In recent
years, attempts have beenmade to introduce a newmethod for
the treatment of lichen planus, as an alternative to standard
management. This method is a photodynamic therapy (PDT),
a form of photochemotherapy, using light that has a definite
wavelength to activate the photosensitizer accumulated in the
cells [8, 9]. One of the novel photosensitizers used in PDT is a
chlorine derivative—Photolon®—a pigment that has been
already applied in the treatment of precancerous lesions
[10]. Its chemical structure corresponds to a partially reduced
porphyrin moiety, whereas its molecular structure is compa-
rable to chlorine e6, which is separated from pheophorbide
during hydrolysis of 5-membered exocyclic dimethyl amine
β-ketoester. Commercial Photolon® contains: chlorine e6
(96.5 % purity according to high performance liquid chroma-
tography) and polyvinylopirrolidone at 1:1 ratio.
The use of PDT has been constantly increasing due to its
numerous advantages, such as selective toxicity towards
inflamed or cancerous tissues, a low risk of complications,
low invasiveness, and rare side effects of low intensity. At
present, PDT is used for the treatment of such diseases as
various types of cancers, leukoplakia, erythroleukoplakia,
dysplasia, and mucosal hypertrophy. Its efficacy varies,
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from complete regression of lesions to the lack of response
to treatment [11–15]. Besides, PDT can be an alternative to
the treatment of OLP for which a universal management
scheme has not yet been determined.
Taking the above into consideration, the study objective
was to clinically evaluate the efficacy of photodynamic
therapy in the treatment of oral lichen planus.
Material and methods
There were 23 patients (17 women and 6 men) aged 31–82
included in the study with 48 lesions of oral lichen planus
diagnosed clinically and histopathologically. Forty lesions
were observed on the lining mucosa—cheeks and lips—and
8 on the masticatory—gums and tongue. Nine of the
patients (three women, six men) were smokers (less than
ten cigarettes per day).
To perform PDT, chlorin-e6-Photolon® (Haemato Poland)
was used as a photosensitizer. The gel containing 20 % chlo-
rine e6 and 10 % dimethyl sulfoxide was applied directly onto
the lesion and the surrounding healthy mucosa 1 h before
illumination, using an occlusive dressing according to the
authors' own method. A sheet of nonwoven fabric, exceeding
the lesion in size by 5–10mm, was carefully covered with a 1-
to 2-mm layer of the photosensitizer. Next, saliva was re-
moved from the vicinity of the lesion, and the prepared fabric
was placed on dried mucosa. Another layer was composed of
a polyethylene sheet of the same size as the nonwoven fabric.
Finally, the dressing was additionally stabilized with a few
layers of sterile gauze.
PDT was performed using a semiconductor laser Hae-
mato LS PDT 660 (Haemato Poland). Application of
660 nm wavelength was transmitted to the lesion via an
optical fiber equipped with a diffuser tip. The laser power
from the end of the optical fiber did not exceed 300 mW. A
series of illuminations was performed using superficial light
energy density of 90 J/cm2. The appointments were sched-
uled at 2-week intervals, but no longer than for ten sessions.
As there was no early response to the treatment, all patients
had to undergo ten PDT sessions.
The treatment efficacy was assessed macroscopically at
one, two, five, and ten appointments. Changes in the lesion
sizes were monitored at the respective PDT sessions accord-
ing to the authors' own method using measurement (in
millimeters) with a calibrated periodontal probe PCPUNC15
(Hu-Friedy, IL, USA). To ensure repeatability of measure-
ments, the authors' own model was used, which was
designed for the need of the study to assess the lesions
according to their size:
Group 0 Lack of evident lesions
Group 1 A lesion smaller than 3 cm2
Group 2 A lesion from 3 to <6 cm2
Group 3 A lesion from 6 to <10 cm2
Group 4 A lesion from 10 to <15 cm2
Group 5 A lesion >15 cm2
In order to analyze age-related data, four age groups were
distinguished: 30–45, 46–60, 61–75, and over 75 years.
Any potentially negative aspects of photodynamic treat-
ment from the patient's point of view were also investigated.
The patients were asked to assess the character of pain and
burning or pricking sensations associated with PDTusing a 0–
3 scale.
The collected data were statistically analyzed with the
use of programs: Statistica for Windows (StatSoft, USA)
and Excel (Microsoft, USA). To assess differences in the
lesion size between groups, the Wilcoxon signed–rank
test was used, and to determine differences in the lesion
size before and after treatment, the paired Student's t test.
The differences were considered statistically significant
at p≤0.05.
Results
On baseline, the mean size of the OPL lesion was 6 cm2±4.5.
The lesions localized on the cheeks and lips were larger
Fig. 1 OLP of the tongue. A 38-year-oldmale, smoker, status before PDT
Fig. 2 Patient from Fig. 1 after PDT—complete regression
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(6.6 cm2±4.63) as compared to those observed on the gums
and tongue (3 cm2±1.9). The lesions with sizes classified into
group 3 and group 1 were the most common. In smokers the
OLP lesions were approximately twice as large as in non-
smokers. Those on the cheeks and lips were similar in women
and men, whereas on the gums and tongue, they were approx-
imately twofold larger in men.
After treatment, improvement was observed in 39 sites,
including 14 with complete regression—13 on the cheeks
and lips and 1 on the gums and tongue (Figs. 1 and 2). In
nine sites, improvement was not evident—in five on the
cheeks and lips and in four on the gums and tongue. The
mean reduction in the size of lesions in OLP patients was
statistically significant (55 %) (p00.00007366). Also statis-
tically significant was the reduction in the lesions on the
cheeks and lips (57.6 %) both in men and women, and
smokers and nonsmokers (on the borderline of significance).
The OLP lesions on the gums and tongue were reduced after
treatment, the mean reduction being 30 %, but the differ-
ences were not statistically significant (p00.56050000). De-
tailed data have been presented in Tables 1 and 2.
Following treatment, the mean lesion reduction within
the cheeks and lips was greatest in group 1 (63.6 %) and
smallest in group 3 (50.8 %). The mean reduction within the
gums and tongue was greatest in group 3 (41.7 %) and
smallest in group 2 (16.7 %). As shown by the analysis of
the lesions in the respective size groups, the mean reduction
in OLP lesions on the cheeks and lips was greater as com-
pared to the gums and tongue (Table 3).
Interestingly, after treatment, no lesions were found to be
extensive (>15 cm2), and only one lesion was 10–15 cm2 in
size. All the other lesions were classified into group 2 and
group 3 (3–10 cm2) (Table 4).
With respect to gender, PDT efficacy for the lesions on
the gums and tongue was similar in women and men (30.6
and 33.3 %, respectively). However, for the lesions on the
Table 1 Mean size, standard
deviation, and mean reduction in
OLP lesion size before and after
treatment
Site of lesion Number
of lesions




Before treatment SD After treatment SD
Lichen planus 48 6 4.5 2.7 2.62 55.0 0.00007366
Cheeks and lips 40 6.6 4.63 2.8 2.81 57.6 0.00006788
Women 28 6.3 4.27 2.8 2.78 55.6 0.00069380
Men 12 7.4 5.29 2.9 2.87 60.8 0.01793000
Smokers 4 11.4 5.44 4.8 0.82 57.9 0.05714000
Nonsmokers 36 6.1 4.21 2.6 2.87 57.4 0.00015430
Gums and tongue 8 3 1.90 2.1 1.21 30.0 0.56050000
Women 7 2.6 1.63 1.9 1.05 26.9 0.66550000
Men 1 6 0 4 0 33.3 –
Smokers 2 4.5 1.50 2.5 0.5 44.4 0.66670000
Nonsmokers 6 2.5 1.75 2 1.35 20.0 0.72730000
Table 2 Number and percentage of OLP lesions before and after
treatment
Site of lesion Number of lesions
All Cured Partly cured Unchanged
Lichen planus 48 14 29.17 % 25 52.08 % 9 18.75 %
Cheeks and lips 40 13 32.50 % 22 55.00 % 5 12.50 %
Women 28 8 28.57 % 15 53.57 % 5 17.86 %
Men 12 5 41.67 % 7 58.33 % 0 0.00 %
Smokers 4 0 0.00 % 4 100.00 % 0 0.00 %
Nonsmokers 36 13 36.11 % 18 50.00 % 5 13.89 %
Gums and tongue 8 1 12.50 % 3 37.50 % 4 50.00 %
Women 7 1 14.29 % 2 28.57 % 4 57.14 %
Men 1 0 0.00 % 1 100.00 % 0 0.00 %
Smokers 2 0 0.00 % 2 100.00 % 0 0.00 %
Nonsmokers 6 1 16.67 % 1 16.67 % 4 66.67 %
Table 3 Surface area and mean reduction in OLP lesions before and





















– – – 20 8±4 55.0
Group 4
(n07)
– – – 12 4±4 63.1
Group 3
(n016)
6 3±1 41.7 % 7.5±1.5 3±3 50.8
Group 2
(n08)
3±0.5 3±1 16.7 % 4±1 2±1.5 57.8
Group 1
(n015)
1.5±0.5 1.5±1.5 25.0 % 1.5±1 1±1 63.6
Lasers Med Sci (2013) 28:311–316 313
cheeks and lips, PDT had a more beneficial effect in men
than in women (51.4 and 68.9 %, respectively).
With respect to the patients' age, the treatment of lesions
on the cheeks and lips was most effective in patients over 75
(66.9 %), whereas least effective in patients aged 61–
75 years (50.9 %). As OLP lesions were not found on the
gums and tongue in all age groups, it was impossible to
make a complete statistical analysis. They were only ob-
served in the group of patients aged 46–60, and their treat-
ment efficacy was 33.3 % (Table 5).
As shown by questionnaire survey, none of the patients
complained of any discomfort during the PDT sessions.
They all located pain sensations at the level of 0 according
to the subjective scale.
Discussion
The analysis of literature data clearly indicates that there is
no standard protocol of OLP lesion treatment which would
be predictable and effective. That is why there are still
searches done for new methods of treatment that would be
more effective and possibly noninvasive, e.g., photodynam-
ic therapy. The first photosensitizers used in PDT were
compounds belonging to the group of hematoporfirin, pho-
tofrin, and meta-tetra (hydroxyphenyl) chlorin. Later, for a
relatively long time, the photosensitizers of choice included
5-aminolevulinic acid (ALA) and dyes—toluidine blue and
methylene blue [16, 17]. So far, there is no photosensitizer
which would meet all clinical demands. Majority of them
have disadvantages like: prolonged skin sensitivity to light,
limited cell selectivity, and unpredictable efficacy [18]. In
our study Photolon® was chosen as its properties seem to be
advantageous as compared to other commonly used photo-
sensitizers. Its absorption of light with increased wavelength
leads to better therapeutic effect, because the photosensitizer
can reach deeper localized lesions without increase of pho-
totoxicity [19–21]. Research performed by Mohamed Ali-
Seyed et al. [22] in 2011 proved that Photolon preferentially
localizes in intracellular organelles in the following se-
quence: nucleus, mitochondria, lysosomes, and Golgi appa-
ratus. Elimination of cancerous cells is done by induction of
CT-26 cell apoptosis which has physiological meaning and
may be related to low drug toxicity. Anticancerous proper-
ties of Photolon were proved in studies of other authors [10,
21]. However, we have not found in the available literature
any reports concerning the use of this photosensitizer for the
treatment of oral lichen planus, which makes any compari-
son impossible.
Studies concerning the use of other photosensitizers in
the treatment of OLP are also rare. Aghahosseini et al. [17]
assessed PDT as an alternative method for the treatment of
lichen planus in 13 patients with 26 mucosa lesions. The
patients rinsed their mouths for 5 min with 5 % aqueous
solution of methylene blue. After 10 min the lesions were
illuminated using a low-energy laser of 632 nm wavelength
and exposure dose of 120 J/cm2. Improvement was noted in
16 lesions and complete remission in 4. The mean reduction

















Group 5 (n02) – 1 1 – – –
Group 4 (n07) – – 3 2 – 2
Group 3 (n016) – – 2 10 2 2
Group 2 (n08) – – – 2 4 2
Group 1 (n015) – – – – 7 8
n number of lesions in the respective size range
Table 5 Comparison of the ef-
ficacy of treatment for OLP in
the respective age groups with
regard to the lesion size
Size
measurement
Location and age group



















– – – – 70.0 % – – 70.0 %
Group 4
(n07)
– – – – 66.7 % 47.2 % – 77.8 %
Group 3
(n016)
– 41.7 % – – 25.0 % 58.0 % 31.7 % 52.8 %
Group 2
(n08)
– 33.3 % 0.0 % – 16.7 % – 71.1 % –
Group 1
(n015)
0.0 % 50.0 % – 0.0 % 100.0 % 57.1 % 50.0 % –
Total (n048) 0.0 % 33.3 % 0.0 % 0.0 % 55.7 % 54.1 % 50.9 % 66.9 %
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in the size of lesions was 44.3 %. In another publication the
same authors described the application of PDT in two
patients with five lichen planus lesions resistant to previous
treatment. The procedure using methylene blue as a photo-
sensitizer caused improvement in four cases—in two cases
the lesions disappeared, and in the other two they were
reduced by 50 % [23].
In the present study we obtained lesion remission or
reduction in approximately 81 % of OLP cases. There was
no response to treatment in 18.75 % of patients. PDT was
more effective in cases of lesions developing on the cheeks
and lips as compared to the tongue and gums. The percent-
age of lesions on the cheeks and lips that remained un-
changed after PDT was 12.5 %, whereas on the tongue
and gums, it was as high as 50 %. However, no definite
conclusions can be drawn from the data due to a very small
number of lesions located on the gums and tongue.
The size of clinical lesions in patients undergoing PDT
decreased significantly in the case of OLP (55 %). The
treatment had the best effects in patients with OLP situated
on the cheeks and lips, where mean size reduction was
57.6 %. A smaller reduction was observed within the mas-
ticatory mucosa, i.e., on the tongue and gums (30 %). This
observation is difficult to interpret and needs to be con-
firmed with a larger number of cases.
Nevertheless, the percentage of cured or partially cured
lesions (81 %) in our study was similar to Aghahosseini et
al.'s [17] (76.9 %), and the protocol used in the presented
study seems to be superior. Patients included in our study
had severe lesions even over 15 cm2 (average, 6 cm2±4.5).
In the study of cited authors, lesions were small (1.8 cm2±
0.7) which in our study would be classified as group 1—the
most mild lesions. After treatment average lesion size was
2.7 cm2±2.62 which gave an area reduction of 3.3 cm2. In
Aghahosseini et al.'s study, after treatment, mean lesion size
was 1 cm2±0.9 which gave an area reduction only of
0.8 cm2. Moreover, the method of measurement in this study
was questionable. It was done with the use of a tongue blade
on which a handmade scale with a different range was
drawn. Repeatability of measurements was not accurate as
may be clearly seen in photos presented in this article. Also,
even side effects were not a significant problem; however,
few patients complained about a mild burning sensation.
The relevant finding of our study was that the efficacy of
PTD was comparable in women and men irrespective of
age. The analysis of age-related PDT efficacy revealed that
it was slightly higher in patients over 46 years of age than in
younger subjects. Besides, since PDT procedures do not
cause any unpleasant sensations and thus do not require
administration of analgesics or anesthetics, they can be
particularly recommended for the elderly. As the therapy
has no side effects, the session can be repeated whenever
recurrence takes place. This is especially important in OLP
which is a chronic disease with often no predictable recur-
rences. The lack of side effects as compared to other PDT
protocols, especially with the use of ALA which is painful,
can be beneficial particularly in patients with long-term
course of disease [18].
Conclusions
The mean 55 % reduction of lesions obtained in the study
favors the introduction of PDT as an alternative therapy for
OLP. However, due to a limited number of relevant literature
data, the method requires further verification with respect to
its efficacy and possibility of long-term remission of the
disease.
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